1. Home
  2. NRXP vs DTST Comparison

NRXP vs DTST Comparison

Compare NRXP & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • DTST
  • Stock Information
  • Founded
  • NRXP 2015
  • DTST 2001
  • Country
  • NRXP United States
  • DTST United States
  • Employees
  • NRXP N/A
  • DTST N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • DTST EDP Services
  • Sector
  • NRXP Health Care
  • DTST Technology
  • Exchange
  • NRXP Nasdaq
  • DTST Nasdaq
  • Market Cap
  • NRXP 32.6M
  • DTST 28.2M
  • IPO Year
  • NRXP N/A
  • DTST N/A
  • Fundamental
  • Price
  • NRXP $3.38
  • DTST $3.52
  • Analyst Decision
  • NRXP Strong Buy
  • DTST
  • Analyst Count
  • NRXP 4
  • DTST 0
  • Target Price
  • NRXP $28.50
  • DTST N/A
  • AVG Volume (30 Days)
  • NRXP 267.4K
  • DTST 33.5K
  • Earning Date
  • NRXP 08-13-2025
  • DTST 08-13-2025
  • Dividend Yield
  • NRXP N/A
  • DTST N/A
  • EPS Growth
  • NRXP N/A
  • DTST N/A
  • EPS
  • NRXP N/A
  • DTST 0.02
  • Revenue
  • NRXP N/A
  • DTST $25,219,312.00
  • Revenue This Year
  • NRXP N/A
  • DTST $12.57
  • Revenue Next Year
  • NRXP N/A
  • DTST $9.29
  • P/E Ratio
  • NRXP N/A
  • DTST $151.10
  • Revenue Growth
  • NRXP N/A
  • DTST N/A
  • 52 Week Low
  • NRXP $1.10
  • DTST $2.93
  • 52 Week High
  • NRXP $6.01
  • DTST $6.82
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 58.54
  • DTST 48.25
  • Support Level
  • NRXP $2.90
  • DTST $3.33
  • Resistance Level
  • NRXP $3.53
  • DTST $3.65
  • Average True Range (ATR)
  • NRXP 0.20
  • DTST 0.13
  • MACD
  • NRXP -0.03
  • DTST 0.02
  • Stochastic Oscillator
  • NRXP 76.19
  • DTST 67.50

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: